High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source | Zendy

Jan F. Scheitz | Zendy; Guillaume Paré | Zendy; Lesly A. Pearce | Zendy; Hardi Mundl | Zendy; W. Frank Peacock | Zendy; Anna Członkowska | Zendy; Mukul Sharma | Zendy; Christian H. Nolte | Zendy; Ashkan Shoamanesh | Zendy; Scott D. Berkowitz | Zendy; Thomas Krahn | Zendy; Matthias Endres | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source

Author(s) -

Jan F. Scheitz,

Guillaume Paré,

Lesly A. Pearce,

Hardi Mundl,

W. Frank Peacock,

Anna Członkowska,

Mukul Sharma,

Christian H. Nolte,

Ashkan Shoamanesh,

Scott D. Berkowitz,

Thomas Krahn,

Matthias Endres

Publication year - 2020

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.120.029628

Subject(s) - medicine , rivaroxaban , aspirin , hazard ratio , cardiology , stroke (engine) , myocardial infarction , troponin t , troponin , confidence interval , atrial fibrillation , warfarin , mechanical engineering , engineering

Optimal secondary prevention for patients with embolic stroke of undetermined source (ESUS) remains unknown. We aimed to assess whether high-sensitivity cardiac troponin T (hs-cTnT) levels are associated with major vascular events and whether hs-cTnT may identify patients who benefit from anticoagulation following ESUS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research